<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03316261</url>
  </required_header>
  <id_info>
    <org_study_id>GPPAD-02</org_study_id>
    <nct_id>NCT03316261</nct_id>
  </id_info>
  <brief_title>Freder1k-Study - Testing Infants for Type 1 Diabetes Risk</brief_title>
  <official_title>Freder1k-Study - Identification of Infants With Increased Type 1 Diabetes Risk for Enrollment Into Primary Prevention Trials</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Helmholtz Zentrum München</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Helmholtz Zentrum München</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The Freder1k-Study will identify infants who have a high genetic risk of type 1 diabetes.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Type 1 diabetes is a common chronic disease in childhood and is increasing in incidence. Type
      1 diabetes is diagnosed by hyperglycemia often in combination with symptoms of weight loss,
      thirst, fatigue and frequent urination, sometimes with ketoacidosis. The clinical onset is
      preceded by an asymptomatic phase identified by serum multiple beta-cell autoantibodies.
      Neonates and infants who are at increased risk to develop multiple beta-cell autoantibodies
      and type 1 diabetes can now be identified using genetic markers. This provides opportunity
      for introducing early therapies to prevent beta-cell autoimmunity and type 1 diabetes.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 19, 2017</start_date>
  <completion_date type="Anticipated">April 2021</completion_date>
  <primary_completion_date type="Anticipated">April 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>greater than 10% risk for multiple beta-cell autoantibodies/type 1 diabetes</measure>
    <time_frame>one-time testing before age 4 months</time_frame>
    <description>increased risk will be identified by risk scores derived from SNPs</description>
  </primary_outcome>
  <enrollment type="Anticipated">168000</enrollment>
  <condition>Identification of Infants at Risk for Type 1 Diabetes</condition>
  <eligibility>
    <study_pop>
      <textblock>
        The Freder1k-Study will identify infants who have a high genetic risk of type 1 diabetes.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age: up to age 4 months

          -  provided written informed consent by custodial parent

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>4 Months</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Anette-Gabriele Ziegler, Prof. Dr. med.</last_name>
    <phone>0800-000 0018</phone>
    <email>contact@gppad.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Institut für Diabetesforschung, Helmholtz Zentrum München</name>
      <address>
        <city>Munich</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anette-G. Ziegler, Prof. Dr.</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <link>
    <url>http://www.gppad.org</url>
  </link>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 12, 2017</study_first_submitted>
  <study_first_submitted_qc>October 19, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">October 20, 2017</study_first_posted>
  <last_update_submitted>February 22, 2018</last_update_submitted>
  <last_update_submitted_qc>February 22, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 23, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Helmholtz Zentrum München</investigator_affiliation>
    <investigator_full_name>Anette-Gabriele Ziegler</investigator_full_name>
    <investigator_title>Director - Institute of Diabetes Research</investigator_title>
  </responsible_party>
  <keyword>infants</keyword>
  <keyword>type 1 diabetes</keyword>
  <keyword>Freder1k</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 1</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

